Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pregaldien JL"'
Autor:
Peterson J; J Lewis Research, Salt Lake City, UT, USA., Drazan D; General Practice for Children and Adolescents, Jindrichuv Hradec, Czech Republic., Czajka H; College of Medical Sciences, University of Rzeszow, Rzeszow, Poland; Individual Specialist Medical Practice, Krakow, Poland., Maguire J; Pfizer Vaccine Research and Development, Pearl River, NY, USA. Electronic address: jason.maguire@pfizer.com., Pregaldien JL; Pfizer Vaccine Research and Development, Brussels, Belgium., Seppa I; Tampere University Vaccine Research Center, Tampere, Finland., Maansson R; Pfizer Vaccine Research and Development, Collegeville, PA, USA., O'Neill R; Pfizer Vaccine Research and Development, Pearl River, NY, USA., Balmer P; Pfizer Vaccine Medical Development and Scientific/Clinical Affairs, Collegeville, PA, USA., Jodar L; Pfizer Vaccine Medical Development and Scientific/Clinical Affairs, Collegeville, PA, USA., Jansen KU; Pfizer Vaccine Research and Development, Pearl River, NY, USA., Anderson AS; Pfizer Vaccine Research and Development, Pearl River, NY, USA., Perez JL; Pfizer Vaccine Research and Development, Collegeville, PA, USA., Beeslaar J; Pfizer Vaccine Research and Development, Hurley, UK.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Dec; Vol. 23 (12), pp. 1370-1382. Date of Electronic Publication: 2023 Aug 11.
Autor:
Drazan D; General Practice for Children and Adolescents, Jindrichuv Hradec, Czech Republic., Czajka H; Faculty of Medicine, University of Rzeszów, Rzeszów, Poland and Individual Specialist Medical Practice, Krakow, Poland., Maguire JD; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Electronic address: Jason.Maguire@pfizer.com., Pregaldien JL; Vaccine Research and Development, Pfizer Inc, Brussels, Belgium., Maansson R; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., O'Neill R; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Anderson AS; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Balmer P; Vaccine Medical and Scientific Affairs, Pfizer Inc, Collegeville, PA, USA., Beeslaar J; Vaccine Clinical Research and Development, Pfizer UK, Hurley, UK., Perez JL; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA.
Publikováno v:
Vaccine [Vaccine] 2022 Jan 21; Vol. 40 (2), pp. 351-358. Date of Electronic Publication: 2021 Dec 24.
Autor:
Beeslaar J; Vaccine Clinical Research and Development, Pfizer Ltd UK, Hurley, UK. Johannes.Beeslaar@pfizer.com., Absalon J; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, NY, USA., Anderson AS; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Eiden JJ; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, NY, USA., Balmer P; Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Harris SL; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Jones TR; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., O'Neill RE; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Pregaldien JL; Vaccine Clinical Research and Development, Pfizer Inc, Brussels, Belgium., Radley D; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, NY, USA., Maansson R; Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA., Ginis J; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Srivastava A; Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA., Perez JL; Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2020 Sep; Vol. 9 (3), pp. 641-656. Date of Electronic Publication: 2020 Jul 22.
Autor:
Fleming DM; Northfield Health Centre, Birmingham, United Kingdom., Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2006 Oct; Vol. 25 (10), pp. 860-9.
Autor:
Latour I; Unité de Biochimie Toxicologique et Cancérologique, Ecole de Pharmacie, Université Catholique de Louvain, Bruxelles, Belgium., Pregaldien JL, Buc-Calderon P
Publikováno v:
Archives of toxicology [Arch Toxicol] 1992; Vol. 66 (10), pp. 743-9.
Publikováno v:
Indian Journal of Pharmacology. May/Jun2013, Vol. 45 Issue 3, p258-263. 6p. 4 Charts, 1 Graph.
Autor:
Rodrigues CMC; Department of Zoology, University of Oxford, Oxford, United Kingdom.; Paediatric Infectious Diseases Unit, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom., Jolley KA; Department of Zoology, University of Oxford, Oxford, United Kingdom., Smith A; Glasgow Dental School, University of Glasgow, Glasgow, United Kingdom.; Scottish Microbiology Reference Laboratory, NHS Greater Glasgow & Clyde, Glasgow, United Kingdom., Cameron JC; Public Health Scotland, Glasgow, United Kingdom., Feavers IM; Department of Zoology, University of Oxford, Oxford, United Kingdom., Maiden MCJ; Department of Zoology, University of Oxford, Oxford, United Kingdom martin.maiden@zoo.ox.ac.uk.
Publikováno v:
Journal of clinical microbiology [J Clin Microbiol] 2020 Dec 17; Vol. 59 (1). Date of Electronic Publication: 2020 Dec 17 (Print Publication: 2020).
Autor:
Ambrose, C., Antonova, E.
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases; Apr2014, Vol. 33 Issue 4, p569-575, 7p
Publikováno v:
Pharmacoepidemiology & Drug Safety; May2007, Vol. 16 Issue 5, pi-xii, 12p
Im seit 1985 jährlich als Buch erscheinenden Arzneiverordnungs-Report werden die Rezepte für die Patienten der gesetzlichen Krankenversicherung (GKV) mit Methoden der evidenzbasierten Medizin analysiert. Seit dieser Zeit bietet der Report eine unab
